Healthcare · Industry
Biotechnology - List & Prices (608 stocks)
| Company | Ticker | Price | Mkt cap | P/E | Div yield |
|---|---|---|---|---|---|
| Seaport Therapeutics, Inc. | SPTX | $19.73 | $1.06B | — | |
| Janux Therapeutics, Inc. | JANX | $16.93 | $1.04B | — | |
| MannKind Corporation | MNKD | $3.05 | $980.71M | — | |
| Jade Biosciences, Inc. | JBIO | $15.13 | $962.23M | — | |
| Savara Inc. | SVRA | $4.67 | $959.50M | — | |
| Monte Rosa Therapeutics, Inc. | GLUE | $11.22 | $957.22M | — | |
| MeiraGTx Holdings plc | MGTX | $9.86 | $946.98M | 11.3 | — |
| ArriVent BioPharma, Inc. | AVBP | $19.12 | $942.76M | — | |
| SpyGlass Pharma, Inc. | SGP | $27.71 | $926.84M | — | |
| Alto Neuroscience, Inc. | ANRO | $23.32 | $915.13M | — | |
| Aktis Oncology, Inc. | AKTS | $16.42 | $913.27M | — | |
| Odyssey Therapeutics, Inc. | ODTX | $19.00 | $913.11M | — | |
| Rigel Pharmaceuticals, Inc. | RIGL | $48.88 | $913.07M | 2.9 | — |
| MoonLake Immunotherapeutics | MLTX | $10.65 | $906.39M | — | |
| Alumis Inc. | ALMS | $6.81 | $881.45M | — | |
| Kura Oncology, Inc. | KURA | $9.88 | $878.93M | — | |
| Cullinan Therapeutics, Inc. | CGEM | $14.89 | $866.56M | — | |
| Obsidian Therapeutics, Inc. | OBX | $13.93 | $860.50M | — | |
| Corvus Pharmaceuticals, Inc. | CRVS | $10.05 | $845.42M | — | |
| Inventiva S.A. | IVA | $3.55 | $838.58M | — | |
| Verastem, Inc. | VSTM | $9.21 | $834.09M | — | |
| SL Science Holding Limited | SLBT | $1.45 | $813.10M | — | |
| Ardelyx, Inc. | ARDX | $3.13 | $808.13M | — | |
| Cybin D/B/A Helus Pharma | HELP | $10.78 | $787.59M | — | |
| Apnimed, Inc. | APMD | $18.90 | $786.82M | 2.6 | — |
| Iambic Therapeutics, Inc. | IAM | $15.80 | $748.93M | — | |
| Geron Corporation | GERN | $1.16 | $745.27M | — | |
| Annexon, Inc. | ANNX | $3.86 | $731.78M | — | |
| Adlai Nortye Group Ltd. | ANL | $11.26 | $725.12M | — | |
| OmniAb, Inc. | OABI | $4.92 | $714.59M | — | |
| Candel Therapeutics, Inc. | CADL | $8.37 | $709.33M | — | |
| Sagimet Biosciences Inc. | SGMT | $9.99 | $708.38M | — | |
| Immix Biopharma, Inc. | IMMX | $8.51 | $705.50M | — | |
| Sana Biotechnology, Inc. | SANA | $2.35 | $703.50M | — | |
| 4D Molecular Therapeutics, Inc. | FDMT | $12.62 | $697.18M | — | |
| Lexicon Pharmaceuticals, Inc. | LXRX | $1.56 | $694.13M | — | |
| Prime Medicine, Inc. | PRME | $3.81 | $691.05M | — | |
| Solid Biosciences Inc. | SLDB | $6.41 | $687.31M | — | |
| Pharming Group N.V. | PHAR | $9.65 | $683.01M | 74.2 | — |
| Nuvectis Pharma, Inc. | NVCT | $20.70 | $675.73M | — | |
| Ginkgo Bioworks Holdings, Inc. | DNA | $10.01 | $674.08M | — | |
| Design Therapeutics, Inc. | DSGN | $10.73 | $671.50M | — | |
| Achieve Life Sciences, Inc. | ACHV | $6.51 | $671.20M | — | |
| Aura Biosciences, Inc. | AURA | $6.46 | $669.93M | — | |
| Wave Life Sciences, Inc. | WVE | $3.37 | $664.05M | — | |
| Avalo Therapeutics, Inc. | AVTX | $12.26 | $657.50M | — | |
| Attovia Therapeutics, Inc. | ATTO | $14.18 | $647.33M | — | |
| Arbutus Biopharma Corporation | ABUS | $4.18 | $640.69M | 5.3 | — |
| Gyre Therapeutics, Inc. | GYRE | $5.90 | $625.60M | — | |
| Olema Pharmaceuticals, Inc. | OLMA | $7.05 | $616.86M | — |
Seaport Therapeutics, Inc.
Healthcare / Biotechnology
- Market Cap
- $1.06B
- P/E
- unprofitable
Janux Therapeutics, Inc.
Healthcare / Biotechnology
- Market Cap
- $1.04B
- P/E
- unprofitable
MannKind Corporation
Healthcare / Biotechnology
- Market Cap
- $980.71M
- P/E
- unprofitable
Jade Biosciences, Inc.
Healthcare / Biotechnology
- Market Cap
- $962.23M
- P/E
- unprofitable
Savara Inc.
Healthcare / Biotechnology
- Market Cap
- $959.50M
- P/E
- unprofitable
Monte Rosa Therapeutics, Inc.
Healthcare / Biotechnology
- Market Cap
- $957.22M
- P/E
- unprofitable
MeiraGTx Holdings plc
Healthcare / Biotechnology
- Market Cap
- $946.98M
- P/E
- 11.3
ArriVent BioPharma, Inc.
Healthcare / Biotechnology
- Market Cap
- $942.76M
- P/E
- unprofitable
SpyGlass Pharma, Inc.
Healthcare / Biotechnology
- Market Cap
- $926.84M
- P/E
- unprofitable
Alto Neuroscience, Inc.
Healthcare / Biotechnology
- Market Cap
- $915.13M
- P/E
- unprofitable
Aktis Oncology, Inc.
Healthcare / Biotechnology
- Market Cap
- $913.27M
- P/E
- unprofitable
Odyssey Therapeutics, Inc.
Healthcare / Biotechnology
- Market Cap
- $913.11M
- P/E
- unprofitable
Rigel Pharmaceuticals, Inc.
Healthcare / Biotechnology
- Market Cap
- $913.07M
- P/E
- 2.9
MoonLake Immunotherapeutics
Healthcare / Biotechnology
- Market Cap
- $906.39M
- P/E
- unprofitable
Alumis Inc.
Healthcare / Biotechnology
- Market Cap
- $881.45M
- P/E
- unprofitable
Kura Oncology, Inc.
Healthcare / Biotechnology
- Market Cap
- $878.93M
- P/E
- unprofitable
Cullinan Therapeutics, Inc.
Healthcare / Biotechnology
- Market Cap
- $866.56M
- P/E
- unprofitable
Obsidian Therapeutics, Inc.
Healthcare / Biotechnology
- Market Cap
- $860.50M
- P/E
- unprofitable
Corvus Pharmaceuticals, Inc.
Healthcare / Biotechnology
- Market Cap
- $845.42M
- P/E
- unprofitable
Inventiva S.A.
Healthcare / Biotechnology
- Market Cap
- $838.58M
- P/E
- unprofitable
Verastem, Inc.
Healthcare / Biotechnology
- Market Cap
- $834.09M
- P/E
- unprofitable
SL Science Holding Limited
Healthcare / Biotechnology
- Market Cap
- $813.10M
- P/E
- unprofitable
Ardelyx, Inc.
Healthcare / Biotechnology
- Market Cap
- $808.13M
- P/E
- unprofitable
Cybin D/B/A Helus Pharma
Healthcare / Biotechnology
- Market Cap
- $787.59M
- P/E
- unprofitable
Apnimed, Inc.
Healthcare / Biotechnology
- Market Cap
- $786.82M
- P/E
- 2.6
Iambic Therapeutics, Inc.
Healthcare / Biotechnology
- Market Cap
- $748.93M
- P/E
- unprofitable
Geron Corporation
Healthcare / Biotechnology
- Market Cap
- $745.27M
- P/E
- unprofitable
Annexon, Inc.
Healthcare / Biotechnology
- Market Cap
- $731.78M
- P/E
- unprofitable
Adlai Nortye Group Ltd.
Healthcare / Biotechnology
- Market Cap
- $725.12M
- P/E
- unprofitable
OmniAb, Inc.
Healthcare / Biotechnology
- Market Cap
- $714.59M
- P/E
- unprofitable
Candel Therapeutics, Inc.
Healthcare / Biotechnology
- Market Cap
- $709.33M
- P/E
- unprofitable
Sagimet Biosciences Inc.
Healthcare / Biotechnology
- Market Cap
- $708.38M
- P/E
- unprofitable
Immix Biopharma, Inc.
Healthcare / Biotechnology
- Market Cap
- $705.50M
- P/E
- unprofitable
Sana Biotechnology, Inc.
Healthcare / Biotechnology
- Market Cap
- $703.50M
- P/E
- unprofitable
4D Molecular Therapeutics, Inc.
Healthcare / Biotechnology
- Market Cap
- $697.18M
- P/E
- unprofitable
Lexicon Pharmaceuticals, Inc.
Healthcare / Biotechnology
- Market Cap
- $694.13M
- P/E
- unprofitable
Prime Medicine, Inc.
Healthcare / Biotechnology
- Market Cap
- $691.05M
- P/E
- unprofitable
Solid Biosciences Inc.
Healthcare / Biotechnology
- Market Cap
- $687.31M
- P/E
- unprofitable
Pharming Group N.V.
Healthcare / Biotechnology
- Market Cap
- $683.01M
- P/E
- 74.2
Nuvectis Pharma, Inc.
Healthcare / Biotechnology
- Market Cap
- $675.73M
- P/E
- unprofitable
Ginkgo Bioworks Holdings, Inc.
Healthcare / Biotechnology
- Market Cap
- $674.08M
- P/E
- unprofitable
Design Therapeutics, Inc.
Healthcare / Biotechnology
- Market Cap
- $671.50M
- P/E
- unprofitable
Achieve Life Sciences, Inc.
Healthcare / Biotechnology
- Market Cap
- $671.20M
- P/E
- unprofitable
Aura Biosciences, Inc.
Healthcare / Biotechnology
- Market Cap
- $669.93M
- P/E
- unprofitable
Wave Life Sciences, Inc.
Healthcare / Biotechnology
- Market Cap
- $664.05M
- P/E
- unprofitable
Avalo Therapeutics, Inc.
Healthcare / Biotechnology
- Market Cap
- $657.50M
- P/E
- unprofitable
Attovia Therapeutics, Inc.
Healthcare / Biotechnology
- Market Cap
- $647.33M
- P/E
- unprofitable
Arbutus Biopharma Corporation
Healthcare / Biotechnology
- Market Cap
- $640.69M
- P/E
- 5.3
Gyre Therapeutics, Inc.
Healthcare / Biotechnology
- Market Cap
- $625.60M
- P/E
- unprofitable
Olema Pharmaceuticals, Inc.
Healthcare / Biotechnology
- Market Cap
- $616.86M
- P/E
- unprofitable
Showing 151–200 of 608 · ranked by market capitalization
Where the trailing year was a loss, P/E appears as “unprofitable”; a dash is missing data.